LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Clinical trials for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC trials appear
Sign up with your email to follow new studies for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HLH patients: targeted drug tested in clinical trial
Disease control Recruiting nowThis study tests a drug called golidocitinib for people with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system attacks the body. The trial will include 28 people aged 14 to 70 with newly diagnosed or returning HLH. The goal is to see if the drug c…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Researchers launch study to unravel mysteries of rare immune disorder sHLH
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop secondary hemophagocytic lymphohistiocytosis (sHLH), a serious immune condition causing fevers and organ damage. Researchers will follow 300 participants for up to 3 years, collecting blood samples and medical data to identify…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC